Table 1.
Twenty most differentially expressed genes with higher expression in YNG stage relative to MGR stage
| Accession | Gene annotation1 | YNG/MGR Fold-change2 | q-value3 |
|---|---|---|---|
| AT1G07930 |
elongation factor 1-alpha / EF-1-alpha |
22.5 |
4.1E-02 |
| AT5G25754 |
unknown protein |
19.2 |
4.7E-02 |
| AT1G11520 |
spliceosome associated protein-related |
18.9 |
3.4E-02 |
| AT1G07940 |
elongation factor 1-alpha / EF-1-alpha |
18.9 |
4.1E-02 |
| AT5G22430 |
unknown protein |
17.6 |
2.2E-02 |
| AT1G75240 |
ARABIDOPSIS THALIANA HOMEOBOX PROTEIN 33 (AtHB33) |
16.2 |
1.4E-02 |
| AT4G14080 |
MATERNAL EFFECT EMBRYO ARREST 48 (MEE48) |
15.4 |
2.2E-02 |
| AT1G01300 |
aspartyl protease family protein located in membrane, plant-type cell wall |
14.6 |
4.0E-02 |
| AT2G07739 |
unknown protein |
14.4 |
4.1E-02 |
| AT3G13470 |
chaperonin, putative with domain Cpn60/TCP-1 (InterPro:IPR002423) |
13.1 |
2.3E-02 |
| AT4G34850 |
chalcone and stilbene synthase family protein involved in phenylpropanoid biosynthetic process |
13.0 |
2.5E-02 |
| AT3G17840 |
RECEPTOR-LIKE KINASE 902 (RLK902) |
12.6 |
3.0E-02 |
| AT1G52030 |
myrosinase binding protein, putative |
12.2 |
2.2E-02 |
| AT5G15720 |
GDSL-MOTIF LIPASE 7 (GLIP7) |
11.6 |
3.7E-02 |
| AT2G18020 |
EMBRYO DEFECTIVE 2296 (EMB2296) |
11.5 |
3.6E-02 |
| AT5G62080 |
protease inhibitor/seed storage/lipid transfer protein (LTP) family protein |
11.4 |
2.9E-02 |
| AT2G01505 |
CLAVATA3/ESR-RELATED 16 (CLE16) |
10.8 |
4.3E-02 |
| AT3G45140 |
LIPOXYGENASE 2 (LOX2) |
10.6 |
1.5E-02 |
| AT1G62950 |
leucine-rich repeat transmembrane protein kinase |
10.4 |
2.7E-02 |
| AT3G55210 |
ARABIDOPSIS NAC DOMAIN CONTAINING PROTEIN 63 (anac063) |
10.0 |
3.0E-02 |
| AT4G04720 | CPK21 | 9.9 | 4.2E-02 |
1Gene descriptions are abbreviated from TAIR10 genome release. Putative functions are stated in lowercase.
2Genes ranked according to fold-change values derived from log2 ratios of YNG (numerator) and MGR (denominator).
3 Derived from false discovery-rate correction of p-values.